Thursday, May 26, 2022 1:38:58 PM
Lykiri, in order to move the ball forward with the UK can you file a new FOI request and simply ask the following. Was there an inspection of Advent Bioservices facility and was a license granted to them? (milestones)
Asking for the entire report of the recent inspection results could be asking for too much.
Their answer to you does not in any way admit they actually inspected a facility and only that if they had done so it is subject to disclosure procedures.
Regulators have this tendency to say they can't disclose things until they are finished (granting them freedom of movement to scam citizens, but also can become unwitting participants to other's schemes). They can be preventing the community from working with regulators to stop scams from continuing (like if NWBO lied about the inspection process or license) when they won't disclose milestones such as a successful inspection, whether one really happened, and if a license was granted, as they become public knowledge due to press releases made by NWBO.
From my vantage point, they could be asking you to refine your request for honest reasons and so you should ask again just for the milestone information.
I would not accept an incomplete, no disclosure answer from them for the new request. I would become more demanding at that point and I hope you and everyone else feel the same.
The way it should work is: as soon as a public company involves a regulator in a filing or press release, any citizen should be able to ask that regulator if it is indeed true, they should be notified immediately either way so that citizen can take action against the company for lying if they did. Failure of the system to be exactly this way is not honest work and police should be involved. Involved in the RIGHT way...
Citizens can speed up approval of NWBO
Asking for the entire report of the recent inspection results could be asking for too much.
Their answer to you does not in any way admit they actually inspected a facility and only that if they had done so it is subject to disclosure procedures.
Regulators have this tendency to say they can't disclose things until they are finished (granting them freedom of movement to scam citizens, but also can become unwitting participants to other's schemes). They can be preventing the community from working with regulators to stop scams from continuing (like if NWBO lied about the inspection process or license) when they won't disclose milestones such as a successful inspection, whether one really happened, and if a license was granted, as they become public knowledge due to press releases made by NWBO.
From my vantage point, they could be asking you to refine your request for honest reasons and so you should ask again just for the milestone information.
I would not accept an incomplete, no disclosure answer from them for the new request. I would become more demanding at that point and I hope you and everyone else feel the same.
The way it should work is: as soon as a public company involves a regulator in a filing or press release, any citizen should be able to ask that regulator if it is indeed true, they should be notified immediately either way so that citizen can take action against the company for lying if they did. Failure of the system to be exactly this way is not honest work and police should be involved. Involved in the RIGHT way...
Citizens can speed up approval of NWBO
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM

